Toronto’s Encycle collaborates with Pfizer on nacellin research
Encycle Therapeutics is working with Pfizer Inc. to further the Toronto-based start-up drug discovery company’s research in synthetic nacellins.
research
UCalgary research project seeks faster diagnoses of rare genetic childhood diseases
A project that is studying how precision medicines can help diagnose and determine treatments for rare genetic childhood diseases is among the six University Calgary […]
U of C Canada Research Chair pursues novel approach in cancer study
When scientists set out to study how cancers function, they typically examine the DNA of the cancer cell. However, one of the University of Calgary’s […]
Genomics project looks to reduce adverse drug reactions in children
Researchers at the University of British Columbia (UBC) and the BC Children’s Hospital Research Institute have partnered with health and wellness company Dynacare, to find […]
Protein engineering market worth US$3.09-B by 2025: Report
Shrinking research costs and faster development times will push the protein engineering market to reach US$3.09 billion in eight years, according to recent market report.
CLS partners with Mitacs
Synchrotron teams up with national not-for-profit to foster innovation The Canadian Light Source synchrotron has signed a memorandum of understanding with Mitacs, a […]